Intensity Therapeutics, Inc. (INTS)
6.48
-0.01
(-0.15%)
USD |
NASDAQ |
Mar 18, 16:00
6.30
-0.18
(-2.78%)
After-Hours: 07:13
Intensity Therapeutics EPS Diluted (Quarterly) : -1.551 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.671M |
| Total Expenses (Quarterly) | 2.671M |
| Enterprise Value | 382.27M |
| Earnings Yield | -163.1% |
| Normalized Earnings Yield | -163.12 |